[Favorable development of Hodgkin's disease treated with E 39]. 1958

A ZAIMI, and T BEN ABDALLAH, and N LEGROS

UI MeSH Term Description Entries
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

A ZAIMI, and T BEN ABDALLAH, and N LEGROS
January 1958, Revista clinica espanola,
A ZAIMI, and T BEN ABDALLAH, and N LEGROS
January 1967, La Tunisie medicale,
A ZAIMI, and T BEN ABDALLAH, and N LEGROS
March 1969, Tijdschrift voor ziekenverpleging,
A ZAIMI, and T BEN ABDALLAH, and N LEGROS
January 1957, Revue medicale de Nancy,
A ZAIMI, and T BEN ABDALLAH, and N LEGROS
February 2000, American journal of clinical oncology,
A ZAIMI, and T BEN ABDALLAH, and N LEGROS
January 1957, Bulletins et memoires de la Societe medicale des hopitaux de Paris,
A ZAIMI, and T BEN ABDALLAH, and N LEGROS
March 1965, The American journal of roentgenology, radium therapy, and nuclear medicine,
A ZAIMI, and T BEN ABDALLAH, and N LEGROS
October 1957, Rivista d'ostetricia e ginecologia pratica,
A ZAIMI, and T BEN ABDALLAH, and N LEGROS
April 1962, Archives des maladies de l'appareil digestif et des maladies de la nutrition,
A ZAIMI, and T BEN ABDALLAH, and N LEGROS
September 1961, Prensa medica argentina,
Copied contents to your clipboard!